Fresenius Medical Care (FMS) Lowered to Equal Weight at Morgan Stanley
Morgan Stanley downgraded shares of Fresenius Medical Care (NYSE:FMS) from an overweight rating to an equal weight rating in a research report sent to investors on Monday morning, MarketBeat reports.
Other analysts also recently issued reports about the stock. Royal Bank of Canada reiterated a hold rating and issued a $44.00 price target on shares of Fresenius Medical Care in a research report on Wednesday, September 13th. Zacks Investment Research downgraded shares of Fresenius Medical Care from a strong-buy rating to a hold rating in a research report on Wednesday, August 16th. Finally, DZ Bank reiterated a buy rating on shares of Fresenius Medical Care in a research report on Monday, November 13th. Two analysts have rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the stock. The stock has an average rating of Hold and a consensus target price of $48.50.
Fresenius Medical Care (NYSE FMS) opened at $51.52 on Monday. The company has a current ratio of 1.22, a quick ratio of 0.98 and a debt-to-equity ratio of 0.55. Fresenius Medical Care has a 52-week low of $39.46 and a 52-week high of $52.38. The stock has a market cap of $32,140.69, a PE ratio of 23.41, a price-to-earnings-growth ratio of 2.35 and a beta of 0.45.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/12/15/fresenius-medical-care-fms-lowered-to-equal-weight-at-morgan-stanley.html.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.
Receive News & Stock Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related stocks with our FREE daily email newsletter.